Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge - An International Multicenter Randomized Control Trial - The PALACE Study

NCT04454229 is registered in ClinicalTrials.gov with Austin Health as lead sponsor.

NCT NCT04454229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04454229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge - An International Multicenter Randomized Control Trial - The PALACE Study
Lead sponsor
Austin Health
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2021
Completion date
December 2, 2022
Enrollment
382 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypersensitivity response, hypersensitivity, delayed, hypersensitivity, immediate